Angiogenesis: An update and potential drug approaches (Review)

Keyphrases

• Abnormal Vasculature 50%
• Angiogenesis 100%
• Antiangiogenic Agents 100%
• Blood Vessel Formation 50%
• Body Dysmorphic Disorder 50%
• Cancer Treatment 50%
• Clinical Development 50%
• Endothelial Cells 100%
• Endothelial Viability 50%
• Endothelium 50%
• In Cancer 50%
• Investigational Agents 50%
• Ligand-directed 50%
• Monoclonal Antibody 50%
• New Agents 50%
• New Blood Vessel 100%
• Potential Drugs 100%
• Recent Advances 50%
• Small Molecules 50%
• Solid Tumors 50%
• Survival Mechanisms 50%
• Targeting Tumor 50%
• Therapeutic Potential 50%
• Tumor 50%
• Tumor Blood Supply 50%
• Tumor Endothelium 50%
• Tumor Growth 50%
• Tyrosine Kinase Inhibitor 50%
• Vascular Disrupting Agents 100%
• Vascular Supply 50%

Medicine and Dentistry

• Angiogenesis 100%
• Antiangiogenic 66%
• Cancer Therapy 33%
• Cell Survival 33%
• Diseases 66%
• Endothelial Cell 100%
• Endothelium 66%
• Malignant Neoplasm 33%
• Monoclonal Antibody 33%
• Neoplasm 33%
• Solid Malignant Neoplasm 33%
• Tumor 33%
• Tumor Progression 33%
• Tumor Vascularization 33%
• Tyrosine-Kinase Inhibitor 33%
• Vascular Bundle 33%
• Vascular-Targeting Agent 100%
• Vascularity 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Antiangiogenic 66%
• Diseases 66%
• Investigational Agent 33%
• Malignant Neoplasm 66%
• Monoclonal Antibody 33%
• Neoplasm 33%
• Protein Tyrosine Kinase Inhibitor 33%
• Solid Malignant Neoplasm 33%
• Tumor Growth 33%
• Tumor Vascularization 33%
• Vascular Targeting Agent 100%